News | November 05, 2021
UK authorises first Covid-19 pill
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The NFI is published to promote the rational use of medicines in the country.
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Subscribe To Our Newsletter & Stay Updated
